Brief: Kronos Bio Q2 Operating Expenses USD 20.711 Million
08/08/2024 21:15
Aug 08 (Reuters) - Kronos Bio Q2 operating income USD -18.023 million. * Q2 basic EPS USD -0.27 * Q2 net income USD -16.2 million
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems